Kellogg Company Us — Kashi Organic Cereal Promise Island Vanilla 16.3oz
by Kellogg Company USMRT 176 Panel Triggers Identified
Clinical Product Assessment
Kellogg Company Us manufactures this product, which has been analyzed against the full MRT 176 panel — comprising 149 foods and 27 chemical additives — to identify potential immune-mediated sensitivities.
MRT Safety Assessment
This product contains 3 MRT-tested substances: Wheat, Cane Sugar, and Vanilla. Wheat is present as whole grain wheat. Cane Sugar appears in two forms (sugar and syrup), and Vanilla is present as both bean and extract. Additionally, ‘natural flavor’ represents an unknown source of potential triggers. Given the count of known triggers and the presence of unknown ingredients, this product is categorized as High Risk and is unsuitable for Phase 1 or Phase 2 of the LEAP protocol. This is procedural data interpretation, not medical guidance.
Risk Summary
- Risk Classification: High Risk
- MRT Triggers Identified: 3
- Safe Ingredients: 0
- Unknown/Ambiguous: 1 (natural flavor)
- LEAP Phase Compatibility: Phase 3 — Practitioner Guided
Flagged Ingredient Mapping
The following ingredients were identified as matching substances on the MRT 176 panel. Each ingredient is mapped to its corresponding panel analyte:
| Ingredient | Maps To (MRT Panel) | Match Type |
|---|---|---|
| whole grain wheat | Wheat | Direct Match |
| cane sugar | Cane Sugar | Direct Match |
| cane syrup | Cane Sugar | Direct Match |
| vanilla bean | Vanilla | Direct Match |
| vanilla extract | Vanilla | Direct Match |
Unknown / Ambiguous Ingredients
The following ingredients could not be definitively mapped to the MRT 176 panel and may contain hidden triggers: natural flavor. Patients should treat these as potential triggers until MRT testing confirms safety. Common examples include ‘natural flavors’ (which can contain any of the 176 tested substances) and ‘spices’ (which may include tested spices like cinnamon, cumin, or black pepper).
LEAP Protocol Guidance
With 3 MRT-tested substances identified, this product is not recommended during Phase 1 or Phase 2 of the LEAP protocol. Phase 3 (Maintenance) patients should consult their Certified LEAP Therapist for personalized evaluation based on their individual MRT results.
UPC Code: 00018627703358
Assessment Methodology
This assessment was generated using Wellbloom’s automated clinical analysis pipeline. Each ingredient in the product was cross-referenced against the complete MRT 176 panel — including 149 food antigens and 27 chemical additives. Ingredient-to-panel mapping uses direct matching, derivative identification (e.g., ‘whey’ maps to Cow’s Milk), and chemical compound recognition. Hidden trigger sources such as ‘natural flavors’ and ‘spices’ are flagged as unknown variables requiring individual verification.
This is procedural data interpretation, not medical guidance. Always consult your Certified LEAP Therapist.
Understanding These Triggers
A major grain trigger distinct from celiac disease. MRT measures inflammatory mediator release to wheat protein, not IgE-mediated gluten allergy. Found in bread, pasta, and many processed foods.
Cane sugar sensitivity is specific to sugarcane-derived sweeteners and is distinct from glucose intolerance. Look for it in ingredient lists as sucrose, cane juice, or turbinado sugar.
Vanilla extract and vanillin (synthetic vanilla) are both MRT-tested. Vanilla appears in baked goods, desserts, and flavored beverages. Check for "natural flavors" which may contain vanilla.
What This Means For Your Diet
With 3 identified triggers, this product has a high concentration of MRT-tested substances. The probability that at least one of these triggers is reactive on your personal panel is statistically significant.
This product is not recommended during Phase 1 (Elimination) or Phase 2 (Reintroduction). It may only be considered during Phase 3 (Maintenance) after your Certified LEAP Therapist has confirmed that all 3 substances scored Green on your individual MRT results.
Products with 3 or more MRT panel triggers require individualized evaluation. Do not attempt to self-assess — your CLT has the clinical training to weigh multiple reactive substances and potential cross-reactivity.
More from Kellogg Company US
Find a LEAP Therapist
Get personalized guidance from a Certified LEAP Therapist in your area.
Browse Practitioners